Maxygen (MAXY) Tops Q2 EPS by 2c; Announces Resignation of Chief Medical Officer
Tweet Send to a Friend
Maxygen, Inc. (Nasdaq: MAXY) reports a Q2 loss of $0.37, 2 cents better than the analyst estimate of ($0.39) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
